ERBB2 and breast carcinoma: Interestingly, the HER2-amplified SUM-225 cell line is also highly sensitive to Alpelisib, an observation made with other HER2-amplified breast cancer cell lines, as can be observed using the Functional-Druggable Target tool on the SLKBase.